[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals (NasdaqGS:REGN) Exits Multiple Russell Growth Indices",
    "summary": "On June 30, 2025, Regeneron Pharmaceuticals (NasdaqGS:REGN) was removed from multiple key indices, a development that may influence its investment appeal and stock liquidity. Over the last month, the company's shares increased by 6%, a move that coincides with Regeneron's Dupixent approval for bullous pemphigoid and its addition to the Russell 1000 Dynamic Index. These events align with broader market trends, as major U.S. indices, including the S&P 500 and Nasdaq, have rallied to new highs...",
    "url": "https://finnhub.io/api/news?id=3ec6501264db3312bb55f0dc93c68e05700c51e68e0e04baf12603982b6a0eea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751304390,
      "headline": "Regeneron Pharmaceuticals (NasdaqGS:REGN) Exits Multiple Russell Growth Indices",
      "id": 135672013,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "On June 30, 2025, Regeneron Pharmaceuticals (NasdaqGS:REGN) was removed from multiple key indices, a development that may influence its investment appeal and stock liquidity. Over the last month, the company's shares increased by 6%, a move that coincides with Regeneron's Dupixent approval for bullous pemphigoid and its addition to the Russell 1000 Dynamic Index. These events align with broader market trends, as major U.S. indices, including the S&P 500 and Nasdaq, have rallied to new highs...",
      "url": "https://finnhub.io/api/news?id=3ec6501264db3312bb55f0dc93c68e05700c51e68e0e04baf12603982b6a0eea"
    }
  },
  {
    "ts": null,
    "headline": "Former 23andMe CEO regains company control as $305m sale to nonprofit approved",
    "summary": "Former 23andMe CEO Anne Wojcicki now runs TTAM Research Institute, which outbid Regeneron in an auction for the bankrupt company’s assets.",
    "url": "https://finnhub.io/api/news?id=55705a9277b8764f2cd16775dd09b171be7032e3daa3da4c25c48c4922ce1619",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751300845,
      "headline": "Former 23andMe CEO regains company control as $305m sale to nonprofit approved",
      "id": 135672014,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Former 23andMe CEO Anne Wojcicki now runs TTAM Research Institute, which outbid Regeneron in an auction for the bankrupt company’s assets.",
      "url": "https://finnhub.io/api/news?id=55705a9277b8764f2cd16775dd09b171be7032e3daa3da4c25c48c4922ce1619"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc.(NasdaqGS: REGN) dropped from Russell 3000 Growth Index",
    "summary": "Regeneron Pharmaceuticals, Inc. dropped from Russell 3000 Growth Index...",
    "url": "https://finnhub.io/api/news?id=25a423c389dfd7b25f93e5aaf6381f2f8fe2274e8bca35fa9939741b962ff502",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751291527,
      "headline": "Regeneron Pharmaceuticals, Inc.(NasdaqGS: REGN) dropped from Russell 3000 Growth Index",
      "id": 135665303,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "Regeneron Pharmaceuticals, Inc. dropped from Russell 3000 Growth Index...",
      "url": "https://finnhub.io/api/news?id=25a423c389dfd7b25f93e5aaf6381f2f8fe2274e8bca35fa9939741b962ff502"
    }
  },
  {
    "ts": null,
    "headline": "Circle initiated, Disney upgraded: Wall Street's top analyst calls",
    "summary": "Circle initiated, Disney upgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=91d382ec10aa66ab1252c117a29c487a966ab89352c0f5cc0b41a333e264b9ba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751290592,
      "headline": "Circle initiated, Disney upgraded: Wall Street's top analyst calls",
      "id": 135653182,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Circle initiated, Disney upgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=91d382ec10aa66ab1252c117a29c487a966ab89352c0f5cc0b41a333e264b9ba"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc.(NasdaqGS: REGN) added to Russell 1000 Dynamic Index",
    "summary": "Regeneron Pharmaceuticals, Inc. added to Russell 1000 Dynamic Index...",
    "url": "https://finnhub.io/api/news?id=dfb134e5b9338495ad79f9acce9103f016c73e4ffa75db9893f8d4986bd0e6d9",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751280759,
      "headline": "Regeneron Pharmaceuticals, Inc.(NasdaqGS: REGN) added to Russell 1000 Dynamic Index",
      "id": 135653623,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "Regeneron Pharmaceuticals, Inc. added to Russell 1000 Dynamic Index...",
      "url": "https://finnhub.io/api/news?id=dfb134e5b9338495ad79f9acce9103f016c73e4ffa75db9893f8d4986bd0e6d9"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc.(NasdaqGS: REGN) dropped from Russell 1000 Growth Index",
    "summary": "Regeneron Pharmaceuticals, Inc. dropped from Russell 1000 Growth Index...",
    "url": "https://finnhub.io/api/news?id=b454889052be6a1eb3bc5315e011eca7f6a9d39926eb3c389e43acc6defe9be6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751274520,
      "headline": "Regeneron Pharmaceuticals, Inc.(NasdaqGS: REGN) dropped from Russell 1000 Growth Index",
      "id": 135651862,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "Regeneron Pharmaceuticals, Inc. dropped from Russell 1000 Growth Index...",
      "url": "https://finnhub.io/api/news?id=b454889052be6a1eb3bc5315e011eca7f6a9d39926eb3c389e43acc6defe9be6"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc.(NasdaqGS: REGN) dropped from Russell 3000E Growth Index",
    "summary": "Regeneron Pharmaceuticals, Inc. dropped from Russell 3000E Growth Index...",
    "url": "https://finnhub.io/api/news?id=418c79e154c4455399e15df3ccd3915320160b494ec8768158762766d2795d71",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751256170,
      "headline": "Regeneron Pharmaceuticals, Inc.(NasdaqGS: REGN) dropped from Russell 3000E Growth Index",
      "id": 135644064,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "Regeneron Pharmaceuticals, Inc. dropped from Russell 3000E Growth Index...",
      "url": "https://finnhub.io/api/news?id=418c79e154c4455399e15df3ccd3915320160b494ec8768158762766d2795d71"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc.(NasdaqGS: REGN) dropped from Russell Top 200 Growth Index",
    "summary": "Regeneron Pharmaceuticals, Inc. dropped from Russell Top 200 Growth Index...",
    "url": "https://finnhub.io/api/news?id=8e51431c884a39e2c3c0d36efd20cd87f1e248d63ddbd2fbdb5f3a16d2e516d9",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751254908,
      "headline": "Regeneron Pharmaceuticals, Inc.(NasdaqGS: REGN) dropped from Russell Top 200 Growth Index",
      "id": 135643185,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "Regeneron Pharmaceuticals, Inc. dropped from Russell Top 200 Growth Index...",
      "url": "https://finnhub.io/api/news?id=8e51431c884a39e2c3c0d36efd20cd87f1e248d63ddbd2fbdb5f3a16d2e516d9"
    }
  }
]